PL3897763T3 - Kompozycje hydrożelowe kapsułkujące cząstki stałe - Google Patents

Kompozycje hydrożelowe kapsułkujące cząstki stałe

Info

Publication number
PL3897763T3
PL3897763T3 PL19839155.9T PL19839155T PL3897763T3 PL 3897763 T3 PL3897763 T3 PL 3897763T3 PL 19839155 T PL19839155 T PL 19839155T PL 3897763 T3 PL3897763 T3 PL 3897763T3
Authority
PL
Poland
Prior art keywords
solid particles
hydrogel compositions
encapsulating solid
compositions encapsulating
hydrogel
Prior art date
Application number
PL19839155.9T
Other languages
English (en)
Inventor
Johan Olsson
Kristoffer Bergman
Morgan KARLSSON
Åke ÖHRLUND
Original Assignee
Galderma Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Holding SA filed Critical Galderma Holding SA
Publication of PL3897763T3 publication Critical patent/PL3897763T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19839155.9T 2018-12-21 2019-12-21 Kompozycje hydrożelowe kapsułkujące cząstki stałe PL3897763T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18215076 2018-12-21
PCT/IB2019/061241 WO2020129028A1 (en) 2018-12-21 2019-12-21 Hydrogel compositions encapsulating solid particles

Publications (1)

Publication Number Publication Date
PL3897763T3 true PL3897763T3 (pl) 2025-10-20

Family

ID=64755379

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19839155.9T PL3897763T3 (pl) 2018-12-21 2019-12-21 Kompozycje hydrożelowe kapsułkujące cząstki stałe

Country Status (12)

Country Link
US (1) US20210308332A1 (pl)
EP (1) EP3897763B1 (pl)
KR (1) KR102920139B1 (pl)
CN (1) CN113286623A (pl)
DK (1) DK3897763T3 (pl)
ES (1) ES3032689T3 (pl)
FI (1) FI3897763T3 (pl)
HU (1) HUE072078T2 (pl)
PL (1) PL3897763T3 (pl)
PT (1) PT3897763T (pl)
SI (1) SI3897763T1 (pl)
WO (1) WO2020129028A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113877000B (zh) * 2021-10-13 2023-01-24 科笛生物医药(无锡)有限公司 注射用微球组合物及其应用
WO2023064624A1 (en) * 2021-10-15 2023-04-20 Prohibix Llc Bulking and collagen stimulating hydrogel compositions
CN116173293B (zh) * 2021-11-29 2025-05-16 爱美客技术发展股份有限公司 一种复合凝胶、制备方法及应用
CN115282336A (zh) * 2022-08-26 2022-11-04 浙江天妍生物科技有限公司 一种含脂肪族聚酯微球多糖混合凝胶及其制备方法和应用
IT202200018585A1 (it) * 2022-09-12 2024-03-12 Glycocore Pharma S R L Procedimento di coniugazione dell’acido ialuronico e coniugati dell’acido ialuronico così ottenuti
IL319702A (en) * 2022-09-21 2025-05-01 Galderma Holding SA Multi-component hydrogel and its uses
US12569589B2 (en) * 2023-05-02 2026-03-10 Allure Medical Spa, P.L.L.C. System and methods for delivering a dermal filler
KR20250077727A (ko) * 2023-11-24 2025-06-02 주식회사 현대메디텍 폴리-l-락틱산 필러의 제조방법 및 그 제조방법으로 제조된 폴리-l-락틱산 필러
FR3162003A1 (fr) * 2024-05-12 2025-11-14 Laboratoires Vivacy Composition de biomateriau comprenant un polyhydroxybutyrate sous forme particulaire
WO2026022744A1 (en) * 2024-07-24 2026-01-29 Galderma Holding SA High-durability glycosaminoglycan gels and methods of making the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
FR2842737B1 (fr) * 2002-07-25 2006-01-27 Centre Nat Rech Scient Particules revetues en surface de hyaluronane ou d'un de ses derives et leur utilisation a titre de vecteurs biologiques pour des matieres actives
WO2005023906A1 (ja) * 2003-09-08 2005-03-17 Chugai Seiyaku Kabushiki Kaisha ヒアルロン酸修飾物、及びそれを用いた薬物担体
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US8192759B2 (en) 2004-07-12 2012-06-05 Isto Technologies, Inc. Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair
US7131319B2 (en) 2004-09-10 2006-11-07 Chip Ganassi Racing Teams, Inc. Method and apparatus for testing a moving vehicle
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
CN101502675B (zh) * 2008-02-04 2013-02-13 山东省药学科学院 一种注射用含大分子水凝胶的透明质酸或其盐的混悬液及其制备方法
FR2955258A1 (fr) * 2010-01-20 2011-07-22 Biopharmex Holding Ltd Composition injectable
CN104258470B (zh) * 2014-05-13 2015-12-30 山东省医疗器械研究所 一种注射用聚乳酸微球和交联透明质酸混合凝胶及其制备方法
US10960716B2 (en) 2015-07-14 2021-03-30 Bridgestone Americas Tire Operations, Llc Method of generating tire load histories and testing tires
CN105126166B (zh) 2015-09-17 2017-11-10 爱美客技术发展股份有限公司 注射用含两亲性微球的透明质酸混合凝胶及其制备方法
US11254792B2 (en) * 2015-12-29 2022-02-22 Galderma Holding SA Method for deacetylation of biopolymers
WO2019121688A1 (en) * 2017-12-22 2019-06-27 Nestlé Skin Health Sa Injectable gel product

Also Published As

Publication number Publication date
EP3897763B1 (en) 2025-04-09
PT3897763T (pt) 2025-06-06
CN113286623A (zh) 2021-08-20
US20210308332A1 (en) 2021-10-07
KR102920139B1 (ko) 2026-01-29
FI3897763T3 (fi) 2025-06-24
ES3032689T3 (en) 2025-07-23
WO2020129028A1 (en) 2020-06-25
EP3897763A1 (en) 2021-10-27
KR20210121020A (ko) 2021-10-07
SI3897763T1 (sl) 2025-10-30
DK3897763T3 (da) 2025-06-23
HUE072078T2 (hu) 2025-10-28

Similar Documents

Publication Publication Date Title
PL3897763T3 (pl) Kompozycje hydrożelowe kapsułkujące cząstki stałe
EP3862318A4 (en) Porous silica particle composition
DK3697376T3 (da) Sammensætning
EP3612228C0 (en) IODINE COMPOSITIONS
EP3606559C0 (en) BIOORTHOGONAL COMPOSITIONS
EP3515467C0 (en) OPHTHALMIC COMPOSITION COMPRISING CICLOSPORINE
EP3688069A4 (en) SILICONE COMPOSITIONS
EP3646858A4 (en) ENCLOSED FORMULATIONS
DK3672631T3 (da) Farmaceutiske sammensætninger indeholdende anti-beta-amyloid-antistoffer
EP3866752A4 (en) Encapsulation
EP3630883A4 (en) Curable compositions
PL3541200T3 (pl) Formulacje proszkowe
EP3589716A4 (en) ADHESION IMPROVEMENT COMPOSITIONS
EP3554470A4 (en) COSMETIC COMPOSITIONS
DK4234656T3 (da) Sammensætninger
EP3669854A4 (en) PHOTOPOLYMERISABLE DENTAL COMPOSITION
EP3708160A4 (en) COMPOSITION OF GINGKO DITERPENE LACTONE
EP4026630A4 (en) Silver particles
PL3706724T3 (pl) Doustne kompozycje ryfamycyny sv
EP3682862C0 (en) HARDENABLE DENTAL COMPOSITION
EP3861039C0 (fr) Compositions d'hydrogels
EP4006524A4 (en) PARTICLE QUANTIFICATION DEVICE
EP3753546A4 (en) SOLID POWDER COSMETIC
EP3725860A4 (en) ENCAPSULATION COMPOSITION
PT3765379T (pt) Composições